GlassScriptPrepare for your visit
Gary Joe Laubacker
Internal Medicine · Ellenton, FL · NPI 1760793517
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$697.08
in general payments reported to CMS, 2019-2025 · $281 in 2025
The $281 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Pfizer INC. $127.20
- Lilly USA, LLC $96.83
- Glaxosmithkline, LLC. $86.15
- Novo Nordisk INC $62.96
- Biohaven Pharmaceuticals, INC. $53.46
- Abbvie INC. $51.28
Drugs and devices associated with these payments
Eliquis Repatha Jardiance Hillrom - Cardiac Ambulatory Monitor Otezla Kerendia Watchman Access System Shingrix Zepbound Mounjaro Cologuard Collection Kit Prevnar 20
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Gary Laubacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/698769/gary-joe-laubacker